{
    "protocolSection": {
        "identificationModule": {
            "nctId": "NCT06043700",
            "orgStudyIdInfo": {
                "id": "R2000-G000-008"
            },
            "organization": {
                "fullName": "Eisai Inc.",
                "class": "INDUSTRY"
            },
            "briefTitle": "A Community-Based Screening Program to Identify Participants at High Risk for Amyloid Pathology",
            "officialTitle": "A Community-Based Screening Program to Identify, Using Blood-Based Biomarkers, Individuals With or Without Alzheimer's Disease Symptoms Who Are at High Risk for Brain Amyloid Pathology",
            "therapeuticArea": [
                "Neurology"
            ],
            "study": "a-community-based-screening-program-to-identify-participants-at-high-risk-for-amyloid-pathology"
        },
        "statusModule": {
            "statusVerifiedDate": "2023-08",
            "overallStatus": "RECRUITING",
            "expandedAccessInfo": {
                "hasExpandedAccess": false
            },
            "startDateStruct": {
                "date": "2023-09-12",
                "type": "ACTUAL"
            },
            "primaryCompletionDateStruct": {
                "date": "2025-03-31",
                "type": "ESTIMATED"
            },
            "completionDateStruct": {
                "date": "2025-03-31",
                "type": "ESTIMATED"
            },
            "studyFirstSubmitDate": "2023-09-12",
            "studyFirstSubmitQcDate": "2023-09-12",
            "studyFirstPostDateStruct": {
                "date": "2023-09-21",
                "type": "ACTUAL"
            },
            "lastUpdateSubmitDate": "2023-11-21",
            "lastUpdatePostDateStruct": {
                "date": "2023-11-24",
                "type": "ACTUAL"
            }
        },
        "sponsorCollaboratorsModule": {
            "responsibleParty": {
                "type": "SPONSOR"
            },
            "leadSponsor": {
                "name": "Eisai Limited",
                "class": "INDUSTRY"
            }
        },
        "oversightModule": {
            "oversightHasDmc": false,
            "isFdaRegulatedDrug": false,
            "isFdaRegulatedDevice": false
        },
        "descriptionModule": {
            "briefSummary": "The primary purpose of this study is to identify participants with or without symptoms of Alzheimer's Disease (AD) that are at high risk for brain amyloid pathology using blood-based biomarkers."
        },
        "conditionsModule": {
            "conditions": [
                "Alzheimer's Disease"
            ],
            "keywords": [
                "Alzheimers Disease",
                "Blood-based biomarkers",
                "Community-based screening"
            ]
        },
        "designModule": {
            "studyType": "OBSERVATIONAL",
            "patientRegistry": false,
            "designInfo": {
                "observationalModel": "COHORT",
                "timePerspective": "PROSPECTIVE"
            },
            "bioSpec": {
                "retention": "SAMPLES_WITH_DNA",
                "description": "Residual blood samples will be retained after obtaining consent from the participants and may be used for future biomarker assessment for AD."
            },
            "enrollmentInfo": {
                "count": 2000,
                "type": "ESTIMATED"
            }
        },
        "armsInterventionsModule": {
            "armGroups": [
                {
                    "label": "All Participants",
                    "description": "Participants with or without symptoms of AD will be enrolled and observed in this study.",
                    "interventionNames": [
                        "Other: No Intervention"
                    ]
                }
            ],
            "interventions": [
                {
                    "type": "OTHER",
                    "name": "No Intervention",
                    "description": "No treatment intervention will be administered.",
                    "armGroupLabels": [
                        "All Participants"
                    ]
                }
            ]
        },
        "outcomesModule": {
            "primaryOutcomes": [
                {
                    "measure": "Number of Participants With Low, Medium, and High Amyloid Pathology",
                    "description": "Number of participants with low, medium, and high amyloid pathology will be estimated.",
                    "timeFrame": "At Screening on Day 1"
                }
            ]
        },
        "eligibilityModule": {
            "eligibilityCriteria": "Inclusion Criteria:\n\n1. Male or female, age 50 to 80 years inclusive, at the time of informed consent\n\n   - Those 50 to 64 years of age must have 1 of the following risk factors confirmed prior to blood sample collection:\n   * First degree relative with dementia onset before age 75,\n   * Known before screening to have at least 1 Apolipoprotein E4 (APOE4) allele, or\n   * Known before screening to have elevated brain amyloid according to previous positron emission tomography (PET), cerebrospinal fluid (CSF), or blood testing\n2. Provide written informed consent\n3. Willing and able to comply with all aspects of the protocol\n4. Willing to be referred to a clinical site if the assessment results meet the criteria\n\nExclusion Criteria:\n\n1. Known uncontrolled medical conditions (example, cardiac, respiratory, gastrointestinal, psychiatric, renal disease, malignant neoplasm)\n2. Participation in an interventional clinical trial study at the time of consent",
            "healthyVolunteers": true,
            "sex": "ALL",
            "minimumAge": "50 Years",
            "maximumAge": "80 Years",
            "stdAges": [
                "ADULT",
                "OLDER_ADULT"
            ],
            "studyPopulation": "Participants with or without symptoms of AD will be screened in this study.",
            "samplingMethod": "NON_PROBABILITY_SAMPLE"
        },
        "contactsLocationsModule": {
            "centralContacts": [
                {
                    "name": "Eisai Medical Information",
                    "role": "CONTACT",
                    "phone": "+1-888-274-2378",
                    "email": "esi_medinfo@eisai.com"
                }
            ],
            "locations": [
                {
                    "facility": "Eisai Site #1",
                    "status": "RECRUITING",
                    "city": "Lady Lake",
                    "state": "Florida",
                    "zip": "32159",
                    "country": "United States",
                    "geoPoint": {
                        "lat": 28.91749,
                        "lon": -81.92286
                    }
                },
                {
                    "facility": "Eisai Site #2",
                    "status": "NOT_YET_RECRUITING",
                    "city": "Orlando",
                    "state": "Florida",
                    "zip": "32801",
                    "country": "United States",
                    "geoPoint": {
                        "lat": 28.53834,
                        "lon": -81.37924
                    }
                }
            ]
        },
        "ipdSharingStatementModule": {
            "ipdSharing": "YES",
            "description": "Eisai's data sharing commitment and further information on how to request data can be found on our website http://eisaiclinicaltrials.com/."
        }
    },
    "derivedSection": {
        "miscInfoModule": {
            "versionHolder": "2024-07-30"
        },
        "conditionBrowseModule": {
            "meshes": [
                {
                    "id": "D000000544",
                    "term": "Alzheimer Disease"
                }
            ],
            "ancestors": [
                {
                    "id": "D000003704",
                    "term": "Dementia"
                },
                {
                    "id": "D000001927",
                    "term": "Brain Diseases"
                },
                {
                    "id": "D000002493",
                    "term": "Central Nervous System Diseases"
                },
                {
                    "id": "D000009422",
                    "term": "Nervous System Diseases"
                },
                {
                    "id": "D000024801",
                    "term": "Tauopathies"
                },
                {
                    "id": "D000019636",
                    "term": "Neurodegenerative Diseases"
                },
                {
                    "id": "D000019965",
                    "term": "Neurocognitive Disorders"
                },
                {
                    "id": "D000001523",
                    "term": "Mental Disorders"
                }
            ],
            "browseLeaves": [
                {
                    "id": "M3885",
                    "name": "Alzheimer Disease",
                    "asFound": "Alzheimer's Disease",
                    "relevance": "HIGH"
                },
                {
                    "id": "M4021",
                    "name": "Amyloidosis",
                    "relevance": "LOW"
                },
                {
                    "id": "M6904",
                    "name": "Dementia",
                    "relevance": "LOW"
                },
                {
                    "id": "M5204",
                    "name": "Brain Diseases",
                    "relevance": "LOW"
                },
                {
                    "id": "M5742",
                    "name": "Central Nervous System Diseases",
                    "relevance": "LOW"
                },
                {
                    "id": "M23002",
                    "name": "Tauopathies",
                    "relevance": "LOW"
                },
                {
                    "id": "M21558",
                    "name": "Neurodegenerative Diseases",
                    "relevance": "LOW"
                },
                {
                    "id": "M21836",
                    "name": "Neurocognitive Disorders",
                    "relevance": "LOW"
                },
                {
                    "id": "M4815",
                    "name": "Mental Disorders",
                    "relevance": "LOW"
                },
                {
                    "id": "M14473",
                    "name": "Psychotic Disorders",
                    "relevance": "LOW"
                },
                {
                    "id": "T2192",
                    "name": "Familial Alzheimer Disease",
                    "asFound": "Alzheimer's Disease",
                    "relevance": "HIGH"
                }
            ],
            "browseBranches": [
                {
                    "abbrev": "BC10",
                    "name": "Nervous System Diseases"
                },
                {
                    "abbrev": "BXM",
                    "name": "Behaviors and Mental Disorders"
                },
                {
                    "abbrev": "All",
                    "name": "All Conditions"
                },
                {
                    "abbrev": "BC18",
                    "name": "Nutritional and Metabolic Diseases"
                },
                {
                    "abbrev": "Rare",
                    "name": "Rare Diseases"
                }
            ]
        }
    },
    "hasResults": false
}